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Purpose. The purpose of this research study was to investigate the effect of Puritan’s Pride 
probiotic on gastrointestinal quality of life of working adults at the Loma Linda Support Services 
Building aged 18 to 65 years. 
Methods. Working adults, 18 to 65 years of age, from the Loma Linda Support Services 
Building were eligible to participate in the study. Subjects were excluded if they were taking 
antibiotics or had taken antibiotics within the previous six months. Subjects who consented were 
given an initial Gastrointestinal Quality of Life Index (GIQLI)12 test and a probiotic supplement 
for 60 days. Subjects’ body composition was also tested during the initial visit. After the 60 days 
of supplementation, subjects returned to retake the GIQLI and to retest their body composition.  
Results. Eleven subjects, 1 male and 10 females, reported for post intervention GIQLI and body 
composition testing. A mean increase of 10.7 (SD= 11.1) in GIQLI scores was found after 
probiotic supplementation (p = .009). No significant differences were found in pre and 
postintervention measurements for BMI, body fat, and weight. The best predictor of 
postintervention GIQLI scores was preintervention GIQLI scores.  
Conclusion. There was an improvement in the related gastrointestinal quality of life in our 
subjects as shown through a significant increase in GIQLI scores and subjects’ commentary. The 
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In the United States, immune-mediated and gut-related health issues are progressively 
increasing.1 According to the National Institute of Health, digestive diseases including, but not 
limited to, irritable bowel diseases and chronic constipation affect approximately 70 million 
Americans annually.2 Because inflammatory and immunologic activation predominantly occurs 
in the gut, achieving and maintaining optimal gut bacteria is advantageous in counteracting these 
inflammatory effects.1 Probiotic supplementation may aid in achieving the optimal balance of 
gut bacteria. These positive effects of probiotic supplementation have garnered the interest of 
many, as reflected in recent statistics provided by the National Center for Complementary and 
Integrative Health. “In 2012, the use of probiotics or prebiotics by adults in the United States was 
four times higher than in 2007.”3 
According to the Food and Agriculture Organization of the United Nations World Health 
Organization, probiotics are defined as “live microorganisms which when administered in 
adequate amounts confer a health benefit on the host.”4 A myriad of bacteria strains exist, but in 
order for a strain to be classified as a probiotic, it must be scientifically shown to have beneficial 
physiological effects, be safe for human consumption, derived from human origin, stable in both 
acid and bile, and adhere to intestinal mucosa.1 Lactobacillus sp. and Bifidobacterium sp. are the 
two most predominant strains studied in the literature because they have shown promising results 
in improving gastrointestinal quality of life.   
Researchers have shown that probiotic use is positively correlated with gastrointestinal 
function regulation and gastrointestinal quality of life improvement.5 More specifically, 
probiotics “promote gut-barrier functions, give maturational signals for the gut-associated 
lymphoid tissues, and balance the generation of pro- and anti-inflammatory cytokines.”1 
Furthermore, researchers have found that probiotic supplementation decreases gastrointestinal 
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transit time, increases stool frequency, and improves stool consistency with no adverse events.6 
Lastly, in some patients with irritable bowel syndrome, probiotic supplementation has decreased 
symptoms in diarrhea-predominant irritable bowel syndrome, reduced bloating, and improved 
bowel movement consistency, all of which led to improved quality of life.7 
In today’s society, advancements in technology have led to more sedentary jobs and a 
demand for higher output in the workplace. This demand can often cause chronic stress in 
employees. Sedentary occupations and occupations performed indoors are associated with a 
higher risk of inflammatory bowel disease. This association may be caused by a lack of physical 
activity and the stress created by the demand for a higher output.8 Job stress has been shown to 
play a role in the development of gastric issues, contribute to negative health behaviors, and 
inhibit workers’ abilities to make positive changes to lifestyle behaviors.9, 10 Additionally, 
chronic stress associated with the workplace is a major risk factor in the pathogenesis of different 
diseases of the gastrointestinal tract including gastroesophageal reflux disease (GERD), peptic 
ulcer, functional dyspepsia, inflammatory bowel disease (IBD), and irritable bowel syndrome 
(IBS).11 
Probiotics, available on the market, contain a variety of strains and differing dosages. 
Despite the number of probiotic choices, we chose to select and analyze one specific probiotic 
supplement brand in order to determine its effectiveness. Therefore, the purpose of this graduate 
student research study was to investigate the effect of Puritan’s Pride probiotic on 
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Methods 
Subjects 
Subjects were recruited through flyers posted within the Loma Linda Support Services Building 
(LLUAHSC 101), as well as through email. Authorized investigators were present on site to 
answer questions and check eligibility on specified dates. Subjects included a total of 11 
employees from LLUAHSC 101 in the city of Loma Linda, California who had never taken a 
probiotic supplement in their lifetime and were between the ages of 18 to 65 years. Subjects were 
excluded if they had taken antibiotics within the last six months. Only subjects from LLUAHSC 
101 were included to limit variability in workplace behavior and activity level. 
Potential subjects who responded to posters and emails were given an informed consent 
form during the initial meeting with employees and prior to the first administration of the 
Gastrointestinal Quality of Life Index (GIQLI) (Appendix A). The investigators were present to 
answer any questions. Subjects had 15 minutes to consider participating in the study. Subjects 
were chosen on a first come, first serve basis, as long as they fulfilled both inclusion and 
exclusion criteria. A total of 17 subjects were recruited, but only 11 subjects completed the 
study.   
  
Supplementation 
The probiotic supplement used was Puritan’s Pride Probiotic 10. The capsules contained 20 
billion live probiotic cultures from 10 probiotic strains. These 10 strains were Lactobacillus 
plantarum, Bifidobacterium bifidum, Lactobacillus rhamnosus, Lactobacillus bulgaricus, 
Lactobacillus salivarius, Lactobacillus brevis, Lactobacillus acidophilus, Bifidobacterium lactis, 
Lactobacillus paracasei, and Lactobacillus casei. The remaining ingredients were gelatin, 
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dicalcium phosphate, silica, vegetable magnesium stearate, and some milk ingredients. Puritan’s 
Pride manufactured the probiotic supplement used and the supplement was purchased online 
through their website (www.puritan.com).  
 
Gastrointestinal Quality of Life Index 
Quality of life was measured using the Gastrointestinal Quality of Life Index (GIQLI) before and 
after a two-month intervention. The GIQLI is a valid and well-known tool for assessing quality 
of life of patients with gastrointestinal complaints, and was developed by a team of four surgeons 
and three methodologists.12 The GIQLI consists of 36 questions which fall into the following 
five main categories: core symptoms, psychological, physical, social, and disease-specific. Core 
symptom questions include abdominal pain, epigastric fullness, bloating, flatus, belching, 
abdominal noises, bowel frequency, enjoyed or restricted eating, and fatigue. An example 
question is “How often during the past 2 weeks have you been troubled by uncontrollable 
stools?” Psychological questions encompass coping with stress, sadness, nervousness, happiness, 
and frustration. Physical items include feeling unwell or unfit, trouble sleeping, changes in 
appearance, and loss in physical strength or endurance. Social questions inquire about 
completion of normal daily activities and recreational activities, as well as worsened personal 
relationships and impairment of sexual life. Lastly, disease-specific questions regarding 
frequency of issues regarding regurgitation, dysphagia, eating speed, nausea, diarrhea, bowel 
urgency, constipation, and blood in the stool are included. Each symptom is rated from 0 to 4 (0 
being the worst and 4 being the best) with a maximum score of 144 points. 
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Procedures 
The experiment was a repeated-measures study in which 11 subjects were given a pretest prior to 
the intervention and a posttest following the intervention. Once consented, subjects were asked 
to fill out a questionnaire regarding current gastrointestinal quality of life. Subject were then 
provided with a 60-day supply (120 capsules) of Puritan’s Pride probiotic supplement, consisting 
of a dosage of 40 billion live cultures. Subjects were instructed to take two capsules daily in the 
morning until posttesting.  
  
Intervention 
During the two months of the study, subjects: 
● Took two capsules of the Puritan’s Pride probiotic supplement every morning. 
● Received weekly email or phone reminders by subject’s preference. 
● Filled in a weekly diary regarding compliance with taking probiotic supplement and core 
symptoms while taking the probiotic supplement (Appendix B). 
● Continued supplementation on the following day for any days missed, and logged it in 
the diary.  
● Returned the diary at the final visit to the investigators. 
● Filled out the same GIQLI at the end of the two month duration. 
 
Data Analysis  
All collected data was analyzed using SPSS ver. 24.0 (SPSS Inc., Chicago, IL, USA) and a p-
value ˂ .05 indicated statistical significance. Paired t-tests were used to determine significant 
changes between pre and post anthropometric measurements and GIQLI scores. Stepwise 
regression tests were used to find the best predictor of the post intervention GIQLI score.  
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Results 
Eleven of the 17 subjects (64.7%) completed the study. Six subjects were lost to follow up. The 
characteristics of the study group are summarized in Table 1. A female predominance (91%) was 
noted among the 11 subjects, with only 1 male subject (9%). The age of subjects ranged from 24 
to 62 years, with a mean of 45.4 years. Based on the subjects’ height and weight, a BMI status 
was able to be determined. The BMI of our subjects ranged from normal to obese, with the mean 
BMI being overweight. Overall, our typical subject was overweight, middle-aged, and 5’5” in 
height. 
We examined the difference between pretest and posttest Gastrointestinal Quality of Life 
Index scores using a paired t-test. We found a mean increase in GIQLI scores of 10.7 (SD = 
11.1) which was significant (p = .009). Even with the one male subject removed, statistical 
analysis still confirmed a significant increase in GIQLI scores, with a mean increase of 9.4 (SD = 
10.7, p = .02). Initially, we had planned on comparing the effect of probiotic supplementation for 
those with high initial GIQLI scores to those with low initial GIQLI scores; however, because of 
low participation and high variability, this comparison was not done. 
We examined the differences between pre and postintervention measurements for BMI, 
body fat, and weight. The mean differences were as follows: change in BMI .10 kg/m2 (SD = 
.34), change in body fat -1.26% (SD = 4.49), change in weight .63 pounds (SD = 1.98). There 
was no significant difference in changes in BMI (p = .36), body fat (p = .36), or weight (p = .31). 
From our stepwise regression tests, we found that the best predictor of posttest GIQLI 
scores was pretest GIQLI scores (p = .001). BMI (p = .85), body fat (p = .67), and weight (p = 
.47) were not significant predictors of post-test GIQLI scores. 





The findings from this study are consistent with current literature that probiotic supplementation 
is related to gastrointestinal function regulation and gastrointestinal quality of life improvement.5 
We observed a significant improvement in GIQLI scores after a two-month intervention of two 
probiotic capsules daily. These results are consistent with a previous study’s findings that 
probiotic supplementation decreases gastrointestinal transit time, increases stool frequency, and 
improves stool consistency with no adverse effects.6  
Although the media suggests that probiotics may promote weight loss, the present study 
did not find significant changes in BMI, body fat, or weight. This suggests that probiotic 
supplementation may not play a significant role in weight management in this population; 
however, although both occurred between the hours of 12:00PM and 2:00PM, anthropometric 
measurements of body fat mass may have been affected by subjects’ hydration status per the 
instruction manual for the InBody scale.  
The primary strength of our study is that our results add to the growing body of 
knowledge and research about probiotic supplementation. Our pilot study shows feasibility, cost 
effectiveness, and timeliness. Even with a small sample size, our findings revealed that probiotic 
supplementation can improve gastrointestinal quality of life. Future studies can use this evidence 
to justify the use of resources and support further investigation of probiotics on gastrointestinal 
quality of life.  Another strength of our study is subject compliance when taking the probiotic 
supplements. Of those who successfully completed the study, compliance was high, mean of 
92.8% compliant. Our study also supports literature findings that the use of probiotic 
supplementation seems to be safe and well tolerated by healthy adults.1  
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This study has a few limitations. First, due to the small sample size and drop out rate, 
findings may not have been fully representative of the population. Another limitation of this 
study is that the subjects may be affected by subject bias. In recent years, consuming probiotics 
has gained popularity in the media as a weight loss method. Knowing this, subjects may have 
consciously or subconsciously followed healthier dietary habits while taking the probiotic 
supplement which may have affected the results.  
In addition to the study’s limitations, there are several confounding factors that may have 
influenced the results of this study. Two possible confounders for this study were physical 
exercise and daily caloric intake. These variables were not tracked or accounted for during the 
course of the study. The time of year during which this study took place could have also 
impacted results, as the study began in October and ended in mid-December. The Thanksgiving 
holiday and the holiday season in general could be confounding factors due to the commonly 
increased food intake during this time of year; however, no documentation of calorie intake was 
collected.  
We suggest a randomized controlled study design with a larger sample and the use of a 
placebo in order to eliminate subject bias which will give a more complete explanation of the 
potential benefits of probiotic supplementation and the mechanisms behind them. Future designs 
may also want to consider providing standardization for any qualitative data collected to account 
for subjects’ perceived physiological improvements. Lastly, accounting for or standardizing 
physical activity and caloric intake may provide more representative results in relation the 
changes in anthropometric measures of BMI, body fat, and weight.  
 
Conclusion 
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Our research study found significant differences between pretest and posttest GIQLI scores in 
employees from LLUAHSC 101. There was a significant improvement in the quality of life in 
our subjects after probiotic supplementation, with patients reporting improved regularity of 
bowel movements, and better sense of overall well-being. There were no significant differences 
in anthropometrics in our subjects after intervention. We found that the best predictor for our 
posttest GIQLI scores were pretest GIQLI scores. Overall, our research study adds to the body of 
knowledge and research surrounding probiotic supplementation for improved gastrointestinal 
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Table 1.  
Summary of Data from 11 Subjects who Completed the Probiotic Supplementation Study 
 
  N Minimum Maximum Mean Standard 
Deviation 
Age (years) 11 24 62 45.4 13.0 
BMI 11 23.0 38.3 29.78 5.13 
Body Fat (%) 11 30.80 53.00 41.25 8.07 
Height(in) 11 60 71 65.0 3.5 
Weight(lb) 11 119.7 246.5 181.1 44.58 
GIQLI 
pretest 
11 71 136 102.4 19.4 
GIQLI posttest 11 83 140 113.1 20.8 
Change in 
GIQLI scores 











Table 2.  
Stepwise Regression Test for Variables predicting GIQLI Posttest Scores 
 






Body Fat .67 
*Stepwise regression test, significance at p≤ .05 
   
 
